Disulfiram Completed Phase 0 Trials for Glioblastomas Treatment

IndicationsStatusPurposePhase
CompletedTreatment0
clinicaltrials.gov IdentifierTitleDrugs
NCT01907165Disulfiram in Treating Patients With Glioblastoma Multiforme After Radiation Therapy With Temozolomide